Edition:
United States

Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

34.26USD
24 Feb 2017
Change (% chg)

$0.20 (+0.59%)
Prev Close
$34.06
Open
$34.25
Day's High
$34.34
Day's Low
$33.99
Volume
6,619,790
Avg. Vol
7,458,587
52-wk High
$37.39
52-wk Low
$28.74

PFE.N

Chart for PFE.N

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. The Company's segments include Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). Its biopharmaceutical products include Lipitor, Sutent and the... (more)

Overall

Beta: 0.99
Market Cap(Mil.): $207,901.80
Shares Outstanding(Mil.): 6,068.35
Dividend: 0.32
Yield (%): 3.74

Financials

  PFE.N Industry Sector
P/E (TTM): 29.38 28.84 29.63
EPS (TTM): 1.17 -- --
ROI: 5.20 13.44 12.96
ROE: 11.58 14.34 14.11

Pfizer subpoenaed in U.S. over patient assistance plans

Pfizer Inc said it received subpoenas from the U.S. Attorney's Office for the District of Massachusetts related to its support for organizations that provide financial help to Medicare patients.

Feb 24 2017

UPDATE 1-Pfizer subpoenaed in U.S. over patient assistance plans

Feb 24 Pfizer Inc said it received subpoenas from the U.S. Attorney's Office for the District of Massachusetts related to its support for organizations that provide financial help to Medicare patients.

Feb 24 2017

BRIEF-Ronald Blaylock elected to Pfizer's board of directors

* Blaylock was also appointed to corporate governance and science and technology committees of Pfizer's board Source text for Eikon: Further company coverage:

Feb 23 2017

BRIEF-Pfizer to cancel listing in the United Kingdom

* Applied to United Kingdom Listing Authority to cancel standard listing of company's common stock

Feb 22 2017

BRIEF-Pfizer said SIX swiss exchange approved delisting of its shares

* Said six swiss exchange approved its application to delist its shares from the six swiss exchange Further company coverage: (Reporting by Silke Koltrowitz)

Feb 22 2017

BRIEF-Momenta Pharmaceuticals announces FDA warning letter to contracted Glatopa

* Momenta Pharmaceuticals announces FDA warning letter to contracted glatopa (glatiramer acetate injection) fill/finish manufacturer

Feb 17 2017

BlackRock's largest mutual fund sours on Google

NEW YORK Managers of BlackRock Inc's largest mutual fund, fearing Trump administration policies could hurt technology companies with hefty foreign revenue streams, have reshuffled their top holdings, and it appears one of the first casualties is Google.

Feb 17 2017

BlackRock's largest mutual fund sours on Google

NEW YORK, Feb 17 Managers of BlackRock Inc's largest mutual fund, fearing Trump administration policies could hurt technology companies with hefty foreign revenue streams, have reshuffled their top holdings, and it appears one of the first casualties is Google.

Feb 17 2017

BRIEF-Pfizer announces top-line results from oral strategy trial of Xeljanz compared to Humira

* Pfizer announces top-line results from the oral strategy trial of xeljanz (tofacitinib citrate) compared to humira(adalimumab)

Feb 16 2017

Trump to meet with retail CEOs who oppose border tax

WASHINGTON, Feb 15 U.S. President Donald Trump will welcome the chief executive officers of Target Corp , Best Buy Co Inc and six other major retailers to the White House on Wednesday morning to discuss tax reform and infrastructure.

Feb 15 2017

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $122.73 +1.03
Novartis AG (NOVN.S) CHF77.60 0.00
Merck & Co., Inc. (MRK.N) $66.16 +0.31
Roche Holding Ltd. (ROG.S) CHF245.20 +0.10
Roche Holding Ltd. (RO.S) CHF248.50 +0.30
Abbott Laboratories (ABT.N) $45.68 +0.28
Bayer AG (BAYGn.DE) €104.25 -0.85
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €80.58 +0.45
AstraZeneca plc (AZN.L) 4,609.00 +8.50

Earnings vs. Estimates